|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS: | ||||||||||||||||||||
| Leasing equipment, net of accumulated depreciation and allowances of $1,249,506 and $1,218,826 | ||||||||||||||||||||
| Net investment in finance leases, net of allowances of $710 and $805 | ||||||||||||||||||||
| Equipment held for sale | ||||||||||||||||||||
| Revenue earning assets | ||||||||||||||||||||
| Unrestricted cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowances of $1,062 and $1,314 | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred financing costs | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Fair value of derivative instruments | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY: | ||||||||||||||||||||
| Equipment purchases payable | ||||||||||||||||||||
| Fair value of derivative instruments | ||||||||||||||||||||
| Accounts payable and other accrued expenses | ||||||||||||||||||||
| Net deferred income tax liability | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Debt, net of unamortized deferred financing costs of $24,437 and $25,245 | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 500,000 shares authorized, none issued | ||||||||||||||||||||
| Common stock, $0.001 par value, 100,000,000 shares authorized, 37,307,134 and 37,167,134 shares issued respectively | ||||||||||||||||||||
| Treasury stock, at cost, 3,911,843 shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated earnings | ||||||||||||||||||||
| Accumulated other comprehensive (loss) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
